Samarium-145 and its use as a radiation source
Patent
·
OSTI ID:1176605
The present invention covers a new radiation source, samarium-145, with radiation energies slightly above those of I-125 and a half-life of 340 days. The samarium-145 source is produced by neutron irradiation of SM-144. This new source is useful as the implanted radiation source in photon activation therapy of malignant tumors to activate the stable I-127 contained in the IdUrd accumulated in the tumor, causing radiation sensitization and Auger cascades that irreperably damage the tumor cells. This new source is also useful as a brachytherapy source.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-76CH00016
- Assignee:
- United States Of America, Department Of Energy
- Patent Number(s):
- H000669
- Application Number:
- 06/938839
- OSTI ID:
- 1176605
- Resource Relation:
- Patent File Date: 1986 Dec 08
- Country of Publication:
- United States
- Language:
- English
Radiation Enhancement with Iodinated Deoxyuridine
|
journal | July 1982 |
Similar Records
Samarium-145 and its use as a radiation source
The theoretical basis and clinical methodology for stereotactic interstitial brain tumor irradiation using iododeoxyuridine as a radiation sensitizer and samarium-145 as a brachytherapy source
Photon-activation therapy
Patent
·
Sun Jan 01 00:00:00 EST 1989
·
OSTI ID:1176605
The theoretical basis and clinical methodology for stereotactic interstitial brain tumor irradiation using iododeoxyuridine as a radiation sensitizer and samarium-145 as a brachytherapy source
Conference
·
Sun Jan 01 00:00:00 EST 1989
·
OSTI ID:1176605
+3 more
Photon-activation therapy
Conference
·
Fri Jan 01 00:00:00 EST 1982
·
OSTI ID:1176605